# Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua

> **NCT06036030** · PHASE2 · COMPLETED · sponsor: **Syamsudin Abdillah,Ph.D, Pharm D** · enrollment: 50 (actual)

## Conditions studied

- Malaria,Falciparum
- Malaria, Vivax
- Malaria
- Infections
- Uncomplicated Malaria
- Uncomplicated Plasmodium Falciparum

## Interventions

- **DRUG:** Dihydroartemisinin
- **DRUG:** Piperaquine
- **DRUG:** Primaquine
- **OTHER:** Momordica Charantia Extract

## Key facts

- **NCT ID:** NCT06036030
- **Lead sponsor:** Syamsudin Abdillah,Ph.D, Pharm D
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-11
- **Primary completion:** 2019-04-16
- **Final completion:** 2019-04-16
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-09-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06036030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06036030, "Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06036030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*